0

544673

MDRC

img img img img
No Data Available

Modern Diagnostic Research C Share Price Update

As of the latest trading session, MODERN DIAGNOSTIC & RESEARCH C is trading at ₹71, up by ₹0.00 or 0.00% from its previous close. The stock has moved between ₹71.00 and ₹71.00 today. Over the past year, the stock has delivered a return of 0.00%. In the last month, it has returned -7.79%.

Investment Returns

Over 1 Month -7.79% Over 3 Months -16.34% Over 6 Months -25.25% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Modern Diagnostic Research C fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 107.20
  • P/E Ratio (TTM) 0.00
  • Beta 1.18
  • Book Value / share 38.16
  • Return on equity 55.22%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.00
info icon alternate text

Modern Diagnostic Research C Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2025 (Values in Cr)
Revenue 77.95
Operating Expense 66.08
Net Profit 8.97
Net Profit Margin (%) 11.50
Earnings Per Share (EPS) 8.15
EBITDA 18.82
Effective Tax Rate (%) 29.55
Particulars MAR 2024 (Values in Cr)
Revenue 67.13
Operating Expense 61.81
Net Profit 5.79
Net Profit Margin (%) 8.62
Earnings Per Share (EPS) 57.95
EBITDA 12.59
Effective Tax Rate (%) 15.59
Particulars MAR 2023 (Values in Cr)
Revenue 56.28
Operating Expense 62.55
Net Profit -5.73
Net Profit Margin (%) -10.18
Earnings Per Share (EPS) -57.32
EBITDA -0.66
Effective Tax Rate (%) 3.53
Particulars MAR 2022 (Values in Cr)
Revenue 60.21
Operating Expense 59.44
Net Profit -1.45
Net Profit Margin (%) -2.40
Earnings Per Share (EPS) -14.51
EBITDA 6.36
Effective Tax Rate (%) 227.19
Particulars MAR 2025 (Values in Cr)
Book Value / Share 18.84
ROE % 55.22
ROCE % 36.90
Total Debt to Total Equity 1.31
EBITDA Margin 24.14
Particulars MAR 2024 (Values in Cr)
Book Value / Share 117.58
ROE % 65.35
ROCE % 30.15
Total Debt to Total Equity 2.02
EBITDA Margin 18.77
Particulars MAR 2023 (Values in Cr)
Book Value / Share 59.63
ROE % -96.14
ROCE % -19.53
Total Debt to Total Equity 2.33
EBITDA Margin -1.17
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.78
Total Assets 64.57
Total Liabilities 64.57
Total Equity 20.72
Share Outstanding 1
Price to Book Ratio 0.00
Return on Assets (%) 13.88
Return on Capital (%) 20.94
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.41
Total Assets 49.48
Total Liabilities 49.48
Total Equity 11.75
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 11.71
Return on Capital (%) 17.99
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.15
Total Assets 36.54
Total Liabilities 36.54
Total Equity 5.96
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -15.68
Return on Capital (%) -26.95
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.63
Total Assets 48.69
Total Liabilities 48.69
Total Equity 11.69
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -2.98
Return on Capital (%) -4.52
Particulars MAR 2025 (Values in Cr)
Net Income 12.72
Cash from Operations 17.52
Cash from Investing -13.14
Cash from Financing -0.21
Net change in Cash 0.37
Free Cash Flow 30.68
Particulars MAR 2024 (Values in Cr)
Net Income 6.86
Cash from Operations 6.66
Cash from Investing -11.03
Cash from Financing 3.36
Net change in Cash 0.25
Free Cash Flow 17.69
Particulars MAR 2023 (Values in Cr)
Net Income -5.94
Cash from Operations -0.11
Cash from Investing 2.10
Cash from Financing -6.47
Net change in Cash -4.48
Free Cash Flow 3.21
Particulars MAR 2022 (Values in Cr)
Net Income 1.13
Cash from Operations 3.15
Cash from Investing -5.19
Cash from Financing 4.50
Net change in Cash 2.94
Free Cash Flow 8.38
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8359.75 61.45 12.68 120200.38 6680.00 8433.15
FORTIS MALAR HOSPITALS LIMITED 53.77 24.33 2.93 100.77 40.75 78.60
SHREE PACETRONIX LTD. 134.20 20.24 2.96 50.32 66.10 283.15
TRANSGENE BIOTEK LTD. 3.06 0.00 2.51 23.19 1.83 5.26
VIMTA LABS LIMITED 478.55 35.16 6.23 2137.65 377.30 902.85
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8359.75 80.07 12.06 120200.38 6680.00 8433.15
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 39.50 0.00 -11.47 29.51 30.30 57.48
KOVAI MEDICAL CENTER & HO 5389.75 25.00 4.95 5896.39 5010.00 6725.00

Modern Diagnostic Research C shareholding pattern

Holding
11.63%
72.85%
0.03%
15.48%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Modern Diagnostic Research C Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
71.00 0.00 redarrow
red-green-graph indicator
14 Bearish
2 Bullish
  • 5 Days 73.40
  • 26 Days 74.30
  • 10 Days 75.00
  • 50 Days 76.00
  • 12 Days 75.10
  • 100 Days 77.00
  • 20 Days 74.60
  • 200 Days 77.00
71.00 PIVOT
First Support 71.00 First Resistance 71.00 Second Support 71.00 Second Resistance 71.00 Third Support 71.00 Third Resistance 71.00
RSI 45.18 ADX 23.89 MACD 0.72 Williams % R -100.00 Commodity Channel Index (CCI) -122.11
Date 2026-05-22 Week 5120.00 Same Day 4800.00 Month 5714.00
1 Year 1.18 3 Year 1.19
Over 1 Month
-7.79% down
Over 1 Year
0.00% down
Over 3 Months
-16.34% down
Over 3 Years
0.00% down
Over 6 Months
-25.25% down
Over 5 Years
0.00% down

Modern Diagnostic Research C Corporate Actions

Top Gainers

Top Losers

Modern Diagnostic Research C Share Price

The Promoter, Mr. Devendra Singh Yadav started its operations of Diagnostic Centre in the name and style of 'Modern X-Ray and Clinical Lab' as Proprietorship firm in year 1985, which was later designated as 'Modern Diagnostic & Research Centre' in 1992. Modern Diagnostic & Research Centre Limited was erstwhile incorporated as 'Modern Diagnostic & Research Centre Private Limited' as a private company, vide Certificate of Incorporation dated April 16, 2012 issued by Registrar of Companies, Delhi .

Thereafter, the Company acquired the business of M/s. Modern Diagnostics & Research Centre, a Proprietorship Concern through Business Transfer Agreement in 2013. Subsequently, its status got converted from private limited into public limited and the name of the Company was changed to 'Modern Diagnostic & Research Centre Limited' pursuant to fresh certificate of incorporation dated December 18, 2024 issued by Registrar of Companies, Central Processing Centre.

Initially, the Firm was engaged in the business of Diagnostic Centre. Today, Company is a services provider in diagnostic and related healthcare tests services in India. It offer a one-stop solution for pathology and radiology testing services such as imaging (including radiology), pathology/clinical laboratory. Through an integrated, nationwide network, it offer a complete diagnostic facilities in radiology and pathology. Company's strength lies in providing a comprehensive, one-stop solution for diagnostic services at affordable prices.

Presently, the Company runs 21 centres which includes 18 laboratories and 3 diagnostics centres in 8 states. Its healthcare tests and services include Ultrasound and colour doppler, CT scan, MRI, Digital X-ray, Mammography, Heart lab, Neuro lab and laboratory, ECG, CBCT, OPG, PFT etc. It perform these tests and services in the clinical laboratories using sophisticated and computerized instruments.

As far as concerned, Company has implemented a PACS (Picture Archiving and Communication System) for efficient data storage, retrieval, and management of medical images. This advanced system allows to store diagnostic images such as X-rays, CT scans, MRIs, and ultrasounds in a digital format, eliminating the need for physical film. Additionally, PACS enables seamless remote access to medical images and reports via the internet. This allows radiologists and healthcare professionals to analyze and interpret diagnostic images from any location, improving workflow efficiency and ensuring faster reporting. With this system, patient data remains securely stored while providing quick and convenient access for accurate diagnosis and timely medical decisions.

Company launched the IPO comprising a fresh issue of 40,99,200 Equity Shares of Rs 10, aggregating to Rs 36.89 crores on January 2, 2026.

Parent organization Indian Private
NSE symbol [-]
Founded 2012
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Modern Diagnostic & Research Centre Ltd?

Answer Field

Modern Diagnostic & Research Centre Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 71.00 as on May 22 2026 01:00 PM.

What is the Market Cap of Modern Diagnostic & Research Centre Ltd Share?

Answer Field

The market cap of Modern Diagnostic & Research Centre Ltd for NSE ₹ 0.00 & for BSE ₹ 107.20 as on May 22 2026 01:00 PM.

What is the 52 Week High and Low of Modern Diagnostic & Research Centre Ltd?

Answer Field

The 52 Week High and Low of Modern Diagnostic & Research Centre Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 100.00 and ₹ 52.90.

What is 1 year return for Modern Diagnostic & Research Centre Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Modern Diagnostic & Research Centre Ltd Share?

Answer Field

As on May 22 2026 01:00 PM the price-to-earnings (PE) ratio for Modern Diagnostic & Research Centre Ltd share is 0.00.

What is the PB ratio of Modern Diagnostic & Research Centre Ltd Share?

Answer Field

As on May 22 2026 01:00 PM, the price-to-book (PB) ratio for Modern Diagnostic & Research Centre Ltd share is 38.16.

How to Buy Modern Diagnostic & Research Centre Ltd Share?

Answer Field

You can trade in Modern Diagnostic & Research Centre Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Modern Diagnostic & Research Centre Ltd Share on Bajaj Broking App?

Answer Field

To buy Modern Diagnostic & Research Centre Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Modern Diagnostic & Research Centre Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|